Covid-19, Coronavirus, SARS-CoV-2 and the small bowel.

  title={Covid-19, Coronavirus, SARS-CoV-2 and the small bowel.},
  author={Klaus E. M{\"o}nkem{\"u}ller and Luc{\'i}a C. Fry and Steffen Rickes},
  journal={Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva},
  • K. Mönkemüller, L. Fry, S. Rickes
  • Published 28 April 2020
  • Biology, Medicine
  • Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva
Although SARS-CoV-2 may primarily enter the cells of the lungs, the small bowel may also be an important entry or interaction site, as the enterocytes are rich in angiotensin converting enzyme (ACE)-2 receptors. The initial gastrointestinal symptoms that appear early during the course of Covid-19 support this hypothesis. Furthermore, SARS-CoV virions are preferentially released apically and not at the basement of the airway cells. Thus, in the setting of a productive infection of conducting… 
COVID-19 and the small intestine
The mechanisms of interaction of SARS-CoV-2 with enterocytes, the fecal-oral route of infection, diagnosis and treatment of COVID-19 with intestinal symptoms are described.
Diseases of the digestive organs and COVID-19
Therapy for patients with COVID-19 should include therapeutic approaches aimed at correcting disorders of the intestinal microbiota, intestinal barrier permeability, and relief of gastroenterological manifestations.
SARS-CoV-2 Gastrointestinal Infection Prolongs the Time to Recover From COVID-19
It is indicated that SARS-CoV-2 GI infection prolongs the duration of Sars-Cov-2 shedding and hospitalization in the patients with COVID-19.
Animal Models of COVID-19. I. Comparative Virology and Disease Pathogenesis
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic has fueled unprecedented development of animal models to understand disease pathogenesis, test therapeutics, and support vaccine development.
Fecal Shedding of SARS-CoV-2 and Its Potential Role in Person-To-Person Transmission and the Environment-Based Spread of COVID-19
The likelihood of SARS-CoV-2 being transmitted via feces or urine appears lower due to the lower relative amounts of virus present in feces/urine, and the biggest risk of transmission will occur in clinical and care home settings where secondary handling of people and urine/fecal matter occurs.
Gastrointestinal coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management
Current-published data of the gastrointestinal aspects involved in SARS-CoV-2 infection, including prevalence and incidence of specific symptoms, the presumptive biological mechanism of GI infection, prognosis, clinical management, and public health-related concerns on the possible risk of oral-fecal transmission are reviewed.
Gastrointestinal symptoms in SARS-CoV‑2 infected: emphasis on increased mucosal permeability
It seems pathogenetically justified to use drugs in the complex therapy of patients with COVID‑19 that contribute to the normalization of intestinal microbiocenosis and intestinal permeability.
COVID-19 and Alimentary Tract: Current Evidence and Recent Recommendations
The pandemic of coronavirus disease 2019 (COVID-19), first reported in China, in December 2019 and since then the digestive tract involvement of  COVID-19 has been progressively described. In this